North Hill Chiropractic Pllc Chiropractor - Sports Physician Medicare: Medicare Enrolled Practice Location: 1625 Meridian Ave E, Edgewood, WA 98371 Phone: 253-927-5530 Fax: 253-927-5163 |
Legacy Chiropractic Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2809 Meridian Ave E, Edgewood, WA 98371 Phone: 253-840-1100 Fax: 253-840-1199 |
Harmony Health Chiropractic & Massage Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2809 Meridian Ave E, Edgewood, WA 98371 Phone: 253-840-1100 Fax: 253-840-1199 |
Dr. Ronald Frank Conti, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 3217 Meridian Ave E, Edgewood, WA 98371 Phone: 253-927-5905 Fax: 253-321-0219 |
Conti Chiropractic Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 3217 Meridian Ave E, Edgewood, WA 98371 Phone: 253-927-5905 |
2r&r Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2809 Meridian Ave E, Edgewood, WA 98371 Phone: 206-963-9894 |
News Archive
The number of children in the Gulf Coast region after Hurricane Katrina who complained of symptoms of bronchitis, pneumonia and other lower respiratory illnesses rose in the years after the storm, according to a 49-page CDC report released on Thursday, the Washington Post reports.
As the final weeks of summer dwindle away, parents are scurrying to provide their kids with all the books, supplies and sports equipment needed to meet this year's upcoming academic and athletic challenges.
Close to 70 percent of men with erectile dysfunction (ED) respond to the ED drug sildenafil. However, only about 50 percent of men with diabetes- a population commonly affected by ED- achieve positive results with sildenafil.
New research reveals that two specific plant-derived compounds may be effective for fighting inflammation and pain. The findings are published in the British Journal of Pharmacology.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry and EGEN, Inc., a privately held biopharmaceutical company focused on developing nucleic acid (DNA and RNAi) therapeutics for the treatment of human diseases, are pleased to announce they have executed a continuation of their feasibility collaboration focused on long-term controlled release of siRNA complexes.
› Verified 4 days ago